Considering that COX-2 expression is induced in necrotic and fibrotic lesions in mdx mice [22], the fact that tetranor-PGDM was stable at 4 and 24 weeks and decreased 12 weeks after tranilast administration suggests that PGD2-related MD progression may have been prevented by tranilast administration. Here, PTGS2 is linked to Menkes disease.